Supurva Healthcare Group Inc
Supurva Healthcare Group, Inc. focuses on acquisitions and development of real estate properties. The company was formerly known as SPRV Holdings, Inc. and changed its name to Supurva Healthcare Group, Inc. in September 2020. The company was incorporated in 1990 and is based in Liverpool, New York.
Supurva Healthcare Group Inc (SPRV) - Net Assets
Latest net assets as of June 2015: $-974.45K USD
Based on the latest financial reports, Supurva Healthcare Group Inc (SPRV) has net assets worth $-974.45K USD as of June 2015.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($354.58K) and total liabilities ($1.33 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-974.45K |
| % of Total Assets | -274.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 351.94 |
Supurva Healthcare Group Inc - Net Assets Trend (2013–2015)
This chart illustrates how Supurva Healthcare Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Supurva Healthcare Group Inc (2013–2015)
The table below shows the annual net assets of Supurva Healthcare Group Inc from 2013 to 2015.
| Year | Net Assets | Change |
|---|---|---|
| 2015-12-31 | $-2.05 Million | -77.68% |
| 2014-12-31 | $-1.16 Million | -711.54% |
| 2013-12-31 | $188.92K | -7.66% |
| 2013-09-30 | $204.59K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Supurva Healthcare Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 676433800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $31.36K | % |
| Other Comprehensive Income | $7.54 Million | % |
| Total Equity | $-3.06 Million | 100.00% |
Supurva Healthcare Group Inc Competitors by Market Cap
The table below lists competitors of Supurva Healthcare Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rainforest Resources Inc
OTCQB:RRIF
|
$0.96 |
|
New Frontier Energy Inc
PINK:NFEI
|
$0.96 |
|
Piksel Inc
PINK:PIKL
|
$0.96 |
|
China BCT Pharmacy Group Inc
PINK:CNBI
|
$0.96 |
|
FG Fitness & Media Group Inc
OTCGREY:FGFT
|
$0.96 |
|
Tradestar Resources Corporation
PINK:TSRR
|
$0.96 |
|
Artificial Life Inc
PINK:ALIF
|
$0.96 |
|
Avix Technologies Inc
PINK:AVIX
|
$0.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Supurva Healthcare Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -2,426,223 to -3,063,704, a change of -637,481.
- Net loss of 700,399 reduced equity.
- Other comprehensive income increased equity by 62,918.
- Other factors decreased equity by 0.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-700.40K | -22.86% |
| Other Comprehensive Income | $62.92K | +2.05% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Supurva Healthcare Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $-3.21 | $0.00 | x |
| 2015-12-31 | $-0.37 | $0.00 | x |
| 2017-12-31 | $-0.32 | $0.00 | x |
| 2018-12-31 | $-0.26 | $0.00 | x |
| 2019-12-31 | $-0.17 | $0.00 | x |
| 2020-12-31 | $-0.17 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
| 2023-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Supurva Healthcare Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-11.96%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -28.67% | 0.00% | 0.00x | 6.33x | $-79.12K |
| 2013 | -102.93% | -848.48% | 0.02x | 6.79x | $-213.34K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-189.25K |
| 2015 | 0.00% | -377.00% | 0.21x | 0.00x | $-68.02K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $188.02K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $179.82K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $189.39K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $193.41K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-713.37K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-441.30K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-394.03K |
Industry Comparison
This section compares Supurva Healthcare Group Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Supurva Healthcare Group Inc (SPRV) | $-974.45K | -28.67% | N/A | $0.96 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |